The University of Chicago Header Logo

Connection

David Grdina to CHO Cells

This is a "connection" page, showing publications David Grdina has written about CHO Cells.
Connection Strength

0.693
  1. Varying levels of radioprotection from the effects of JANUS neutrons in repair-deficient xrs-5 hamster cells treated with azacytidine. Radiat Res. 1994 Dec; 140(3):437-40.
    View in: PubMed
    Score: 0.118
  2. Protection against radiation-induced mutagenesis at the hprt locus by spermine and N,N"-(dithiodi-2,1-ethanediyl)bis-1,3-propanediamine (WR-33278). Mutagenesis. 1994 Jul; 9(4):355-60.
    View in: PubMed
    Score: 0.115
  3. Relationships between cytoprotection and mutation prevention by WR-1065. Mil Med. 2002 Feb; 167(2 Suppl):51-3.
    View in: PubMed
    Score: 0.049
  4. Effects of thiols on topoisomerase-II alpha activity and cell cycle progression. Cell Prolif. 1998 Oct-Dec; 31(5-6):217-29.
    View in: PubMed
    Score: 0.039
  5. Repression of c-myc gene expression by the thiol and disulfide forms of the cytoprotector amifostine. Carcinogenesis. 1997 Dec; 18(12):2457-9.
    View in: PubMed
    Score: 0.036
  6. WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells. Cell Prolif. 1997 Jun-Jul; 30(6-7):283-94.
    View in: PubMed
    Score: 0.035
  7. The inhibition of radiation-induced mutagenesis by the combined effects of selenium and the aminothiol WR-1065. Mutat Res. 1996 Sep 23; 356(2):147-54.
    View in: PubMed
    Score: 0.034
  8. Expression of thymidine kinase messenger RNA and a related transcript is modulated by radioprotector WR1065. Cancer Res. 1995 Nov 01; 55(21):4788-92.
    View in: PubMed
    Score: 0.032
  9. The effects of cycloheximide and WR-1065 on radiation-induced repair processes: a mechanism for chemoprevention. Carcinogenesis. 1995 Nov; 16(11):2699-705.
    View in: PubMed
    Score: 0.032
  10. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action. Carcinogenesis. 1995 Apr; 16(4):767-74.
    View in: PubMed
    Score: 0.030
  11. Chromosome terminal deletion formation in Chinese hamster ovary cells. Mutat Res. 1994 Nov 01; 311(1):125-31.
    View in: PubMed
    Score: 0.029
  12. Inhibition of topoisomerase II alpha activity in CHO K1 cells by 2-[(aminopropyl)amino]ethanethiol (WR-1065). Radiat Res. 1994 Apr; 138(1):44-52.
    View in: PubMed
    Score: 0.028
  13. Effects of growth media on cell cycle progression in CHO cells exposed to the radioprotector WR-1065. Cell Prolif. 1992 Nov; 25(6):643-50.
    View in: PubMed
    Score: 0.026
  14. Reversion of radiosensitivity in azacytidine-treated XRS5 cells does not result in full radioprotection by WR-1065. Int J Radiat Oncol Biol Phys. 1992; 23(5):999-1002.
    View in: PubMed
    Score: 0.024
  15. Chemical protection and cell-cycle effects on radiation-induced mutagenesis. Cell Prolif. 1992 Jan; 25(1):23-9.
    View in: PubMed
    Score: 0.024
  16. Amifostine metabolite WR-1065 disrupts homologous recombination in mammalian cells. Radiat Res. 2010 Feb; 173(2):175-83.
    View in: PubMed
    Score: 0.021
  17. Radiosensitivity of mammalian cell lines engineered to overexpress cytosolic glutathione peroxidase. Radiat Res. 2001 Apr; 155(4):536-42.
    View in: PubMed
    Score: 0.011
  18. Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity. Cancer Res. 1999 Jul 01; 59(13):3059-63.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.